In mid-July, the FDA approved Leqembi, a series of injections that specifically target the plaques that build up in the brains of Alzheimer's patients. Those plaques are what cause the memory loss, behavioral changes, and terminal decline.That medication was given to Gail Youngsdale. Three years ago, Gail's Alzheimer's disease was progressing. At the time, Leqembi was a trial drug. Doctors gave her injections to target the nine spots of plaque in her brain.Now? They're gone and Gail has gotten married and gotten most of her memory back.We're out here reversing Alzheimer's y'all. pic.twitter.com/OuNJCax9Hq— L (@SomeBitchIIKnow) September 3, 2026Every single spot...